Skip to content
DraconiticResearch
Search Sources API
186,631 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY-NCInternational medical case reports journal

Focal Epithelial Hyperplasia in a Somali Child: A Case Report and Review of Management with Topical Imiquimod.

5 affiliations
  1. 1Department of Dermatology, Shafi Hospital, Mogadishu, Somalia.
  2. 2Department of Dermatology, Royal Hospital, Mogadishu, Somalia.
  3. 3Department of Gastroenterology, Samakaal Hospital, Mogadishu, Somalia.
  4. 4Faculty of Medicine and Surgery, Salaam University, Mogadishu, Somalia.
  5. 5Neglected Tropical Diseases Unit, Ministry of Health and Human Services, Mogadishu, Somalia.

Abstract

Background

Focal epithelial hyperplasia (FEH), also known as Heck's disease, is a rare, benign, contagious condition of the oral mucosa associated primarily with human papillomavirus (HPV) types 13 and 32. It predominantly affects children and adolescents and is often underreported in many regions.Case presentation

We report the case of an 8-year-old Somali girl who presented with a 3.5-year history of asymptomatic, progressively increasing oral mucosal lesions. Clinical examination revealed multiple soft, flat-topped, verrucous papules involving the lower labial, buccal, lingual mucosa, and gingiva. The patient presented with poor oral hygiene; however, feeding difficulties, malnutrition, systemic symptoms, previous treatment, and similar lesions among family members were absent. A clinical diagnosis of focal epithelial hyperplasia was made (Figure 1). The patient was treated with off-label topical imiquimod 5% cream applied three times weekly at bedtime. After two weeks of therapy, the patient developed local adverse reactions, including mucosal erythema, erosion, crusting, and minor focal bleeding (Figure 2). During this phase, she experienced localized burning discomfort, mild pain, and transient feeding difficulty, which necessitated a temporary 1-week treatment holiday and supportive local care. Following seven weeks of resumption, complete clinical resolution (Figure 3) of the lesions was achieved within ten weeks of total management, with no recurrence observed over a 16-month follow-up period.Conclusion

This case represents the first documented report of focal epithelial hyperplasia in Somalia and highlights the utility of off-label and non-invasive topical imiquimod 5% cream. Increased clinical awareness is essential for accurate diagnosis and appropriate management, particularly in underreported settings.

Related

  1. Development and Optimization of a Lupeol-Loaded Bilosomal Gel for Enhanced Topical Therapy of Imiquimod-Induced Psoriasis.
    Mohammad Hamza, Soumya Samanta, Mohammed Faheem Khan +5
    Gels (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Synchronous Nodular Epithelial Hyperplasia and Type A Microthymoma Adjacent to a Thymic Cyst: A Report of a Rare Case.
    Yujiro Bunno, Marino Yamamoto, Ryohei Miyazaki +2
    CureusPeer-reviewedCC BYFull textNeurologyEurope PMC
  3. Neointimal Hyperplasia and Restenosis: Epidemiology, Pathophysiology, Animal Models, Clinical Features, Diagnosis, and Management.
    Kaixu Wang, Daiyu Zhang, Yu Hu +4
    MedCommPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Non-interventional and medical management of lower urinary tract symptoms related to benign prostatic hyperplasia in men: Guidelines of the French LUTS Committee (CTMH)
    Julien Anract, Clément Klein, Clément Sarrazin +9
    The French Journal of UrologyPeer-reviewedCC BY2 citedGeneral biologyGeneral medicineHAL
  5. Optimizing Dry Eye Disease Management with Topical Anti-Inflammatory or Immunomodulatory Drugs Combined with Artificial Tears: A Systematic Review and Meta-Analysis of Clinical Trials
    Eugenia Piragine, Sara Veneziano, Lorenzo Flori +6
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
BibTeX
@article{hersi2026focal,
  title = {{Focal Epithelial Hyperplasia in a Somali Child: A Case Report and Review of Management with Topical Imiquimod.}},
  author = {Mohamed A Hersi and Mohamud M Abdulkadir and Mohamed Abdulkadir Hassan-Kadle and Mohamed Hassan Mohamud and Abdulkarim Ahmed Mohamud and Mohamed Adam Jama},
  journal = {International medical case reports journal},
  year = {2026},
  month = oct,
  doi = {10.2147/imcrj.s632816},
  url = {https://europepmc.org/article/MED/42899195},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Focal Epithelial Hyperplasia in a Somali Child: A Case Report and Review of Management with Topical Imiquimod.
AU  - Mohamed A Hersi
AU  - Mohamud M Abdulkadir
AU  - Mohamed Abdulkadir Hassan-Kadle
AU  - Mohamed Hassan Mohamud
AU  - Abdulkarim Ahmed Mohamud
AU  - Mohamed Adam Jama
PY  - 2026
DA  - 2026/10/15
JO  - International medical case reports journal
DO  - 10.2147/imcrj.s632816
UR  - https://europepmc.org/article/MED/42899195
AB  - Background  Focal epithelial hyperplasia (FEH), also known as Heck's disease, is a rare, benign, contagious condition of the oral mucosa associated primarily with human papillomavirus (HPV) types 13 and 32. It predominantly affects children and adolescents and is often underreported in many regions.Case presentation  We report the case of an 8-year-old Somali girl who presented with a 3.5-year history of asymptomatic, progressively increasing oral mucosal lesions. Clinical examination revealed multiple soft, flat-topped, verrucous papules involving the lower labial, buccal, lingual mucosa, and gingiva. The patient presented with poor oral hygiene; however, feeding difficulties, malnutrition, systemic symptoms, previous treatment, and similar lesions among family members were absent. A clinical diagnosis of focal epithelial hyperplasia was made (Figure 1). The patient was treated with off-label topical imiquimod 5% cream applied three times weekly at bedtime. After two weeks of therapy, the patient developed local adverse reactions, including mucosal erythema, erosion, crusting, and minor focal bleeding (Figure 2). During this phase, she experienced localized burning discomfort, mild pain, and transient feeding difficulty, which necessitated a temporary 1-week treatment holiday and supportive local care. Following seven weeks of resumption, complete clinical resolution (Figure 3) of the lesions was achieved within ten weeks of total management, with no recurrence observed over a 16-month follow-up period.Conclusion  This case represents the first documented report of focal epithelial hyperplasia in Somalia and highlights the utility of off-label and non-invasive topical imiquimod 5% cream. Increased clinical awareness is essential for accurate diagnosis and appropriate management, particularly in underreported settings.
SN  - 1179-142X
ER  -